60 Degrees Pharmaceuticals, Inc.
NASDAQ: SXTP0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Geoffrey Stuart Dow
- Employees
- 3
- Headquarters
- Washington, United States
- IPO year
- 2023
- Market cap
- $1.4M
- Website
- https://www.60degreespharma.com
Loading SXTP…
Loading profile data…Frequently asked questions about SXTP
What does 60 Degrees Pharmaceuticals, Inc. (SXTP) do?
60 Degrees Pharmaceuticals, Inc. is a specialty pharmaceutical firm dedicated to developing and bringing to market therapies aimed at preventing and treating infectious diseases within the United States. The company currently offers Arakoda, an approved medication for malaria prophylaxis. Its pipeline includes several investigational drugs: Tafe...
Where does SXTP trade?
60 Degrees Pharmaceuticals, Inc. (SXTP) trades on the NASDAQ Capital Market.
What sector is SXTP in?
60 Degrees Pharmaceuticals, Inc. (SXTP) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of 60 Degrees Pharmaceuticals, Inc.?
Geoffrey Stuart Dow is the chief executive officer of 60 Degrees Pharmaceuticals, Inc. (SXTP).
Where is 60 Degrees Pharmaceuticals, Inc. headquartered?
60 Degrees Pharmaceuticals, Inc. is headquartered in United States.
Does SXTP pay a dividend?
60 Degrees Pharmaceuticals, Inc. (SXTP) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SXTP go public?
60 Degrees Pharmaceuticals, Inc. (SXTP) completed its initial public offering in 2023.